Organigram, a company that engages in the production and sale of medical marijuana, agreed to acquire a 43$ stake in Edibles & Infusions, a producer of cannabis-infused products, from AgraFlora Organics, a cannabis company, for $35m. “AgraFlora and Organigram have enjoyed working towards the closing of the EIC Transaction. The EIC facility was designed to handle both smaller-batch artisanal manufacturing and, more importantly, large-scale nutraceutical-grade and high-efficiency production with a view to gaining EU GMP certification. Organigram found the facility’s design and flexibility attractive, while AgraFlora is now better positioned with its net share of the transaction proceeds to explore new opportunities, potentially in the United States. As such, we view this transaction as truly mutually beneficial,” Elise Coppens, AgraFlora CEO and Director.